Blood - Components, Testing & Collection

22-Mar-2012 | News-Press Release

This market insight report gives an insight into global Blood – Components, Testing & Collection market. The report also provides market analytics by Product Type. The market is divided by Type into Blood Components and Blood Testing & Collecting Devices and Other (Artificial Blood and Research) ; and by Blood Products into Plasma Products, Cellular Components, and Whole Blood; and Blood Testing & Collecting Devices into Management and Monitoring Instruments, Immunoassays and Other.
 Information regarding latest products & technologies also find a mention in the report. Projections and estimates are also illustrated by geographic regions encompassing North America, Europe, Japan, Asia-Pacific, and Rest of World (RoW) with 154 exclusive graphically represented exhibits. Compilation of Worldwide Patents and Research related to Blood and related products are also provided. Market Survey
 Report Highlights

 This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –
* Identify Market Opportunities
 * Review and Analyze Global and Regional Markets
 * Gauge Market Potential for your Products
 * Identify Competition
 * Use Market Research for exploring new areas
 * Acquire Meaningful Guidelines for Strategic Planning
 * Gear up for Market Entry
 * Get Actionable Information
 Analytics and data presented in each report pertain to several parameters such as –
* Global and Regional Market Sizes, Market Shares, Market Trends
 * Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 * Technology Trends
 * Corporate Intelligence
 * Key Companies By Sales, Brands, Products
 * Other Strategic Business Affecting Data
 Key Report Findings
Europe and the US together account for almost 2/3rd of the global blood banking and blood products market and maximum growth are also estimated in these regions only. The growth in Asia-Pacific market is estimated about 4-5% over 2001-2010. The plasma products and blood components are estimated to constitute about 69% of the market in 2008. Automated blood collection and processing systems as well as prior-screening capabilities of latest assays are expected to enhance quantity and quality of blood. The European market of whole blood and cellular components in 2008 is estimated about US$5 billion. In 2005, the global market of human-derived blood products and blood banking & investigating devices exceeded $25 billion.
 A sudden increase in new infections all over the world is a matter of worry to the blood banking and blood products industry. Even though people are now alert to the different infections, the industry is yet to overcome difficulties such as security, and the accessibility to good quality blood. This has led to very strict safety measurements being taken for both the donors as well as the blood banks which have to be adhered to before any transfusion is carried out. The risk of diseases spread through transfusions has decreased due to conduction of thorough testing and screening techniques and also with the assistance from latest technologies.
 Current conversion rates from plasma-derived to recombinant factor products are increasing the standard factor product cost. Collecting blood manually continues to be the most productive technique for collecting blood and the systems that are used in these procedures are extremely important to the blood banking industry. Since there is a decrease in the number of blood donations throughout the world, the income from this segment is presently undergoing a decline. Devices with inline filters are making up for the decline. The automated collection devices sector is forecast to show marginal and constant growth, as increased portions of donated blood components are collected in this method. Throwaways which allow automated plasma collection will take front seat in the automated collection devices field.
 Blood banks now await a safe technology that will combine with their processing systems and decrease the danger of transfusion-related infections to almost nil. The success of the market is ascertained by the capacity to provide cost-effective technologies.
 For more information kindly visit :
Blood - Components, Testing & Collection
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Follow us on twitter:!/Sandhya3B

Show HTML Embed Snippet

This release was submitted by a Newsbox user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment